Equine-assisted Therapy and Anorexia Nervosa

April 29, 2024 updated by: Institut Mutualiste Montsouris

Equine-assisted Therapy in the Management of Adolescent Patients With Severe Anorexia Nervosa: a Qualitative Study

Background: Severe anorexia nervosa is a complex psychiatric pathology with limited therapeutic tools to reduce morbidity and mortality. Equine-assisted therapy could provide additional therapeutic benefits.

Objectives : The investigators aimed to explore the effects of equine assisted therapy on the experience of adolescents with severe anorexia nervosa.

Méthods : Using a qualitative approach based on Interpretative Phenomenological Analysis, the investigators conducted semi-structured interviews with nine participants who had taken part in equine-assisted therapy sessions.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

9

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Paris, France, 75014
        • Institut Mutualiste Montsouris

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Female participants who were between 13 and 25 years old and had completed at least 2 sessions of equine-assisted therapy during a hospitalization for anorexia nervosa between 2016 and 2022 in the psychiatric hospitalisation unit of the Institut Mutualiste Montsouris (Paris)

Description

Inclusion Criteria:

  • having participated in at least 2 equine-assisted therapy sessions
  • being or having been hospitalised between 2016 and 2022 in the psychiatric hospitalisation unit of the Institut Mutualiste Montsouris (Paris)
  • ICD 10 diagnosis F50.0/ F.50.1
  • female gender
  • age between 13 and 25
  • fluent French
  • consent (including parents if minor participant)

Exclusion Criteria:

  • having been under the care of C. Lepy (resident) during hospitalisation at the Institut Mutualiste Montsouris (Paris)
  • refusal to participate on the part of the participant or the holder of parental authority.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Semi-structured face-to-face interviews of patients was carried out using the Interpretative Phenomenological Analysis (IPA) method.
Time Frame: Between November 2020 and May 2022, when participants had completed at least 2 sessions of equine-assisted therapy during a hospitalization for anorexia nervosa

Interpretative Phenomenological Analysis (IPA) method : this method explores people's perception of experience and how they make sense of it.

IPA is based on three epistemological foundations: phenomenology, hermeneutics and ideography. The phenomenological approach seeks to explore the participant's understanding of the world. Hermeneutics assumes the interpretive dimensions of the results, both in the participant's access to their own experience, and in the researcher's access to the participant's perception of the world.
Between November 2020 and May 2022, when participants had completed at least 2 sessions of equine-assisted therapy during a hospitalization for anorexia nervosa

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Institut Mutualiste Montsouris

Investigators

  • Principal Investigator: Aurélie LETRANCHANT, MD, Institut Mutualiste Montsouris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 2, 2020

Primary Completion (Actual)

May 30, 2022

Study Completion (Actual)

May 30, 2022

Study Registration Dates

First Submitted

March 29, 2024

First Submitted That Met QC Criteria

April 29, 2024

First Posted (Actual)

May 1, 2024

Study Record Updates

Last Update Posted (Actual)

May 1, 2024

Last Update Submitted That Met QC Criteria

April 29, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EQUINE-ASSISTED THERAPY

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anorexia Nervosa

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe